We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$638M
AUM Growth
+$38.4M
Cap. Flow
-$9.1M
Cap. Flow %
-1.43%
Top 10 Hldgs %
40.81%
Holding
137
New
3
Increased
14
Reduced
41
Closed
5

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$7.6M
2
AMD icon
Advanced Micro Devices
AMD
+$2.74M
3
AAPL icon
Apple
AAPL
+$2.71M
4
BGS icon
B&G Foods
BGS
+$806K
5
HAL icon
Halliburton
HAL
+$707K

Sector Composition

Rank Sector Weight
1 Technology 28.23%
2 Financials 16.59%
3 Healthcare 15.13%
4 Consumer Discretionary 13.77%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALB icon
26
Albemarle
ALB
$15.5B
$11.1M 1.75%
152,651
-600
-0.4% -$40.1K
CRM icon
27
Salesforce
CRM
$162B
$10.8M 1.69%
66,380
+4,700
+8% +$737K
JPM icon
28
JPMorgan Chase
JPM
$956B
$9.06M 1.42%
64,970
+300
+0.5% +$38.5K
PXD
29
DELISTED
Pioneer Natural Resource Co.
PXD
$8.51M 1.33%
+56,250
New +$7.49M
GOOG icon
30
Alphabet (Google) Class C
GOOG
$4.35T
$7.43M 1.16%
111,100
-3,480
-3% -$225K
CSCO icon
31
Cisco
CSCO
$483B
$6.41M 1%
133,676
CVX icon
32
Chevron
CVX
$382B
$6.15M 0.96%
51,043
-1,084
-2% -$128K
AMAT icon
33
Applied Materials
AMAT
$415B
$5.67M 0.89%
92,805
-3,000
-3% -$169K
PG icon
34
Procter & Gamble
PG
$340B
$3.85M 0.6%
30,855
-550
-2% -$67.3K
AFL icon
35
Aflac
AFL
$61.1B
$3.48M 0.55%
65,806
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$133B
$1.81M 0.28%
8,278
-545
-6% -$110K
WFC.PRL icon
37
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.65B
$1.7M 0.27%
1,175
REGN icon
38
Regeneron Pharmaceuticals
REGN
$83.2B
$1.67M 0.26%
4,451
VZ icon
39
Verizon
VZ
$195B
$1.63M 0.26%
26,618
-157
-0.6% -$9.47K
RDS.A
40
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.63M 0.25%
27,574
MSFT icon
41
Microsoft
MSFT
$3.76T
$1.55M 0.24%
9,838
-300
-3% -$44.1K
ABBV icon
42
AbbVie
ABBV
$438B
$1.43M 0.22%
16,145
GILD icon
43
Gilead Sciences
GILD
$165B
$1.43M 0.22%
21,980
-600
-3% -$39.1K
DOW icon
44
Dow Inc
DOW
$22.1B
$1.35M 0.21%
24,754
+16,725
+208% +$864K
VRSN icon
45
VeriSign
VRSN
$26.5B
$1.16M 0.18%
6,038
TWO.PRE
46
DELISTED
Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock
TWO.PRE
$1.12M 0.18%
44,450
MMM icon
47
3M
MMM
$93.9B
$1.08M 0.17%
7,296
+2,721
+59% +$381K
XOM icon
48
ExxonMobil
XOM
$657B
$1.03M 0.16%
14,711
+1,880
+15% +$130K
AMGN icon
49
Amgen
AMGN
$226B
$907K 0.14%
3,762
SCHW
50
Charles Schwab
SCHW
$187B
$883K 0.14%
18,557

Similar funds

Kelly Lawrence W & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Kelly Lawrence W & Associates held 137 positions worth $638M, up 6.4% from $600M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Kelly Lawrence W & Associates's Q4 2019 filing shows 3 new, 14 increased, 41 reduced and 5 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 56,250 shares worth $8.51M. The largest sale was SLB Ltd, an estimated $7.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • Kelly Lawrence W & Associates's largest Q4 2019 buy was Pioneer Natural Resource Co.: 56,250 shares worth $8.51M.
  • Kelly Lawrence W & Associates added most to Dow Inc in Q4 2019, an estimated $864K increase.
  • Kelly Lawrence W & Associates's biggest Q4 2019 reduction was SLB Ltd, cutting an estimated $7.6M.
  • Kelly Lawrence W & Associates fully exited DuPont de Nemours in Q4 2019, selling an estimated $589K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 41% of its $638M portfolio in Q4 2019.
  • Kelly Lawrence W & Associates opened 3 new positions and closed 5 in Q4 2019.
  • Kelly Lawrence W & Associates's portfolio value rose 6.4% quarter-over-quarter to $638M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2019, filed 14 Feb 2020.